Can a digital dispenser solve the pill problem for patients with multiple diseases?

NCT ID NCT07175545

Not yet recruiting Disease control Sponsor: Lusofona University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests Mobili®, a portable digital dispenser that automatically gives the right pills at the right time. Researchers will enroll 96 adults with diabetes or heart disease who take at least two daily medications. Participants use the device for a period, and the study measures how many pills are taken correctly, along with blood sugar and blood pressure levels. The goal is to see if this technology, supported by pharmacists, can improve medication adherence and health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mobili® digital medication dispenser (device)
What this could lead to: If successful, this could provide a practical tool to help people with multiple chronic conditions take their medications correctly, reducing complications and hospital visits.
What could go wrong: This is a small, early-stage crossover trial with only 96 participants. The device requires smartphone use, which may limit who can benefit. Results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder diabetes mellitus Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES DIABETES DOSE ADMINISTRATION AIDS MEDICATION ADHERENCE POLYPHARMACY TECHNOLOGY IN HEALTH

Contacts and locations

Locations

Universidade Lusófona - Centro Universitário de Lisboa

Lisbon, 1749-024, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.